nVerses Capital »

Silverback Therapeutics shares owned by nVerses Capital

Quarter-by-quarter ownership of Silverback Therapeutics (SPRY) shares owned by nVerses Capital from 13F filings

Historical chart of nVerses Capital investment in Silverback Therapeutics

23:59:59.999Sep 29, 202423:59:59.999500:00:00Sep 30, 202400:00:00.000500:00:00.00130.449k30.4495k30.45k30.4505k30.451k20992,099.521002,100.52101
Value ($)Share countHistorical SPRY position of nVerses Capital Source: stockzoa.comValue ($)Share count

Tip: Access up to 7 years of quarterly data

All positions including Silverback Therapeutics held by nVerses Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Silverback Therapeutics by nVerses Capital

Quarter filed Position value Share count Share price at filing
2024-09-30 $31k 2.1k 14.50

More positions owned by nVerses Capital

None None

View all positions for nVerses Capital

Top funds holding Silverback Therapeutics

RA Capital Management
Deerfield Management Company
OrbiMed Advisors
BlackRock
Sr One Capital Management
Alliancebernstein
Vanguard Group
State Street Corporation
Franklin Resources
Alyeska Investment Group
Geode Capital Management
Woodline Partners
Nextech Invest
FMR
Citadel Advisors

View all funds holding Silverback Therapeutics